Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapy

Hepatology

Volumn 26, Issue 6, 1997, Pages 1573-1579

  Meng, Ling Jie ^a   Reyes, Humberto ^b   Axelson, Magnus ^c   Palma, Joaquin ^b   Hernandez, Ismael ^b   Ribalta, Jose ^b   Sjövall, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CHILE   (Chile)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; 5ALPHA PREGNANE 3ALPHA,20ALPHA DIOL; 7ALPHA HYDROXYCHOLEST 4 EN 3 ONE; 7ALPHA HYDROXYCHOLESTEROL; ELTANOLONE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BILIARY EXCRETION; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGESTERONE METABOLISM; STEROID METABOLISM;

EID: 0030663220     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260627     Document Type: Article

References (33)

1. Svanborg A. A study of recurrent jaundice in pregnancy. Acta Obstet Gynecol Scand 1954;33:434-444.
2. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. HEPATOLOGY 1982;2:87-96.
3. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 1992;21:905-921.
4. Bacq Y, Myara A, Brechot M-C, Hamon C, Studer E, Trivin F, Metman E-H. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J Hepatol 1995;22:66-70.
5. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993;13:289-301.
6. Reyes H. Intrahepatic cholestasis: a puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997;12:211-216.
7. Adlercreutz H, Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med 1970;49:630-648.
8. Kreek MJ. Female sex steroids and cholestasis. Semin Liver Dis 1987;7:8-23.
9. Solomon S, Fuchs F. Progesterone and related neutral steroids. In: Fuchs F, Klopper A, eds. Endocrinology of Pregnancy. New York: Harper & Row, 1971:66-100.
10. Baillie TA, Curstedt T, Sjövall K, Sjövall J. Production rates and metabolism of sulphates of 3β-hydroxy-5α-pregnane derivatives in pregnant women. J Steroid Biochem 1980;13:1473-1488.
11. Anderson RA, Baillie TA, Axelson M, Cronholm T, Sjövall K, Sjövall J. Stable isotope studies on steroid metabolism and kinetics: sulphates of 3α-hydroxy-5α-pregnane derivatives in human pregnancy. Steroids 1990;55:443-457.
12. Sjövall K. Gas Chromatographic determination of steroid sulphates in plasma during pregnancy. Ann Clin Res 1970;2:393-408.
13. SjövallJ, Sjövall K. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels. Ann Clin Res 1970;2:321-237.
14. Giusti G, Piccinino F, Ricciardi I, Delrio G, Sagnelli E, Manzillo G. Abnormal steroid sulfates in plasma of women with intrahepatic cholestasis of pregnancy. Acta Hepato-Gastroenterol 1979;26:203-206.
15. Meng LJ, Reyes H, Palma I, Hernandez I, Ribalta J, Sjövall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol 1997;27:346-357.
16. Laatikainen T, Karjalainen O. Excretion of conjugates of neutral steroids in human bile during late pregnancy. Acta Endocrinol-Cop 1972;60:775-788.
17. Laatikainen T, Karjalainen O, Jänne O. Excretion of progesterone metabolites in urine and bile of pregnant women with intrahepatic cholestasis. J Steroid Biochem 1973;4:641-648.
18. Eriksson H, Gustafsson J-Å, Sjövall J, Sjövall K. Excretion of neutral steroids in urine and faeces of women with intrahepatic cholestasis of pregnancy. Steroids Lipids Res 1972;3:30-48.
19. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, Alvarez C, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. HEPATOLOGY 1992;15:1043-1047.
20. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, Liepins J, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997; in press.
21. Meng LJ, Reyes H, Palma I, Hernandez I, Ribalta J, Sjövall J. Profiles of steroids and bile acids in plasma of patients with intrahepatic cholestasis of pregnancy - effect of ursodeoxycholic acid therapy. In: van Berge Henegouwen GP, van Hoek B, De Groote J, Matern S, Stochbrügger RW, eds. Cholestatic Liver Diseases. Dordrecht: Kluwer Academic Publishers, 1994:45-49.
22. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval S, Almuna R, Liepins J, et al. Ursodeoxycholic acid therapy in cholestasis of pregnancy. In: Reyes HB, Leuschner U, Arias IM, eds. Pregnancy, Sex Hormones and the Liver. Dordrecht: Kluwer Academic Publishers, 1995:223-227.
23. Meng LJ, Sjövall J. Method for combined analysis of profiles of conjugated progesterone metabolites and bile acids in serum and urine of pregnant women. J Chromatogr Biomed Sci Appl 1997;688:11-26.
24. Axelson M, Aly A, Sjövall J. Levels of 7α-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett 1988;239:324-328.
25. Axelson M, Björkhem I, Reihner E, Einarsson K. The plasma level of 7α-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7α-hydroxylase in man. FEBS Lett 1991;284:216-218.
26. Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentration of 7α-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. HEPATOLOGY 1996;24:123-126.
27. Ribalta J, Reyes H, Gonzalez MC, Iglesias J, Arrese M, Poniachik J, Molina C. S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo controlled study with negative results. HEPATOLOGY 1991;13:1084-1089.
28. Stolz A, Takikawa H, Sugiyama Y, Kuhlenkamp J, Kaplowitz N. 3α-hydroxysteroid dehydrogenase activity of the Y′ bile acid binders in rat liver cytosol. Identification, kinetics, and physiologic significance. J Clin Invest 1987;79:427-434.
29. Takikawa H, Stolz A, Kuroki S, Kaplowitz N. Oxidation and reduction of bile acid precursors by rat hepatic 3α-hydroxysteroid dehydrogenase and inhibition by bile acids and indomethacin. Biochim Biophys Acta 1990;1043:153-156.
30. Oude Elferink RP, Jansen PL. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther 1994;64:77-97.
31. ++ mechanisms defective in cholestasis. J Clin Invest 1993;92:2984-2993.
32. Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullak-Ublick GA, Sauter G, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996;110:1553-1563.
33. Boyer JL, Soroka CJ. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology 1995;109:1600-1611.